Showing results (121-130 of 134) with videos related to
Sort By:
Pageof 14
Neuro-Oncology Pediatrics|March 30, 2026
Alternative splicing in pediatric central nervous system tumors highlights oncofetal candidate CLK1 exon 4Ammar S Naqvi, Patricia J Sullivan, Ryan J Corbett, et al.Cancers|April 30, 2021
A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood NeuroblastomaLaura D Gamble, Stefania Purgato, Michelle J Henderson, et al.Nature Communications|November 21, 2025
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumorsRyan J Corbett, Rebecca S Kaufman, Shelly W McQuaid, et al.Biorxiv : the Preprint Server for Biology|December 18, 2023
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastomaAmber K Weiner, Alexander B Radaoui, Matthew Tsang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2025
Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor PredispositionPeter N Fiorica, Lisa Golmard, Jung Kim, et al.Cancer Cell|October 25, 2024
A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastomaAmber K Hamilton, Alexander B Radaoui, Matthew Tsang, et al.Biorxiv : the Preprint Server for Biology|July 19, 2024
The Open Pediatric Cancer ProjectZhuangzhuang Geng, Eric Wafula, Ryan J Corbett, et al.Gigascience|September 2, 2025
The Open Pediatric Cancer ProjectZhuangzhuang Geng, Eric Wafula, Ryan J Corbett, et al.Nature Genetics|June 30, 2015
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutationsThomas F Eleveld, Derek A Oldridge, Virginie Bernard, et al.Nature Genetics|January 22, 2013
The genetic landscape of high-risk neuroblastomaTrevor J Pugh, Olena Morozova, Edward F Attiyeh, et al.Pageof 14